文献速递心外重症与机械循环支持

左心室辅助装置桥接心脏移植者的肾脏结局

Renal Outcomes in Patients Bridged to Heart Transplant With a Left Ventricular Assist Device.
PubMed 文献 · Ann Thorac Surg · 2020-01-03

基于2009至2018年UNOS登记数据,纳入18,307例首次接受心脏或心肾联合移植的成人,比较使用耐久性LVAD桥接(BTT)与未使用者的移植后肾衰竭风险。多变量logistic回归显示LVAD BTT与移植后肾衰竭无独立关联(OR 1.13,95%CI 0.86-1.49),在术前肾功能不全者中亦无关联(aOR 1.40,95%CI 0.91-2.18)。

要点

  • LVAD桥接心脏移植与移植后肾衰竭无独立关联(OR 1.13,95%CI 0.86-1.49)。
  • 术前肾功能不全者中LVAD BTT亦与移植后肾衰竭无关联(aOR 1.40,95%CI 0.91-2.18)。
  • LVAD BTT患者接受心肾联合移植比例更低(2.7% vs 4.8%,P < .001)。

核心结论

  • LVAD桥接心脏移植策略与移植后肾衰竭风险无独立关联,且不受基线肾功能影响。

研究设计与样本

  • 回顾性队列研究,查询2009至2018年UNOS登记库,纳入18,307例首次接受心脏或心肾联合移植的成人,按移植前是否使用耐久性LVAD分层,主要结局用多变量logistic回归评估。

主要发现

  • 7,887例(43%)为LVAD BTT,10,420例(57%)未使用LVAD。
  • LVAD BTT患者基线eGFR略高(68.7 vs 65.8 mL/min,P < .001),接受心肾联合移植比例更低(2.7% vs 4.8%,P < .001)。
  • 多变量回归显示LVAD BTT与移植后肾衰竭无独立关联(OR 1.13,95%CI 0.86-1.49);术前肾功能不全者中亦无关联(aOR 1.40,95%CI 0.91-2.18)。

临床怎么用

  • LVAD桥接心脏移植不增加移植后肾衰竭风险,慢性肾病患者可考虑单纯心脏移植而不必因LVAD桥接而叠加肾移植。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with end-stage heart failure are increasingly being bridged to heart transplant (BTT) with mechanical circulatory support; however the association between a left ventricular assist device (LVAD) BTT strategy and posttransplant renal outcomes is unclear. The aim of this study was to analyze the association of LVAD BTT with the development of posttransplant renal failure using a large national registry. METHODS: We queried the 2009 to 2018 United Network for Organ Sharing registry for all adults undergoing first-time heart or heart-kidney transplantation and stratified patients by use of pretransplant durable LVAD. The primary outcome of interest was posttransplant renal failure, which was evaluated with multivariable logistic regression. RESULTS: Of 18,307 patients meeting inclusion criteria, 7887 were (43%) and 10,420 were not (57%) BTT with an LVAD. BTT patients had slightly better baseline renal function (estimated glomerular filtration rate, 68.7 vs 65.8 mL/min, P < .001) and were less likely to receive a heart-kidney transplant (2.7% vs 4.8%, P < .001). On multivariable logistic regression, LVAD BTT strategy was not independently associated with posttransplant renal failure (odds ratio, 1.13; 95% confidence interval, 0.86-1.49). Similarly LVAD BTT among patients with preoperative renal dysfunction was not associated with posttransplant renal failure (adjusted odds ratio, 1.40; 95% confidence interval, 0.91-2.18). CONCLUSIONS: BTT with an LVAD does not appear to be associated with worse renal outcomes regardless of baseline renal function. Furthermore, an LVAD BTT strategy in patients with chronic kidney disease may enable clinicians to identify candidates suitable for isolated heart transplantation without increasing their risk for posttransplant renal failure.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Jawitz OK, Fudim M, Raman V, et al. Renal Outcomes in Patients Bridged to Heart Transplant With a Left Ventricular Assist Device. Ann Thorac Surg. 2020. PMID: 31904371. doi:10.1016/j.athoracsur.2019.11.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。